Healio
SearchLoading
Healio
SearchLoading
Author headshot

Hilary M. DuBrock, MD

DuBrock is Director of the Mayo Clinic Pulmonary Hypertension Fellowship Program in Minnesota.
Choose a Section

Most recent by Hilary M. DuBrock, MD

SPONSORED CONTENT
February 20, 2025
2 min read
Save

Patients with PAH show more benefit with seralutinib if deemed responders

Among patients with pulmonary arterial hypertension treated with 72-week seralutinib, those deemed responders had more improved measures, according to a poster presented at the Pulmonary Vascular Research Institute 2025 Annual Congress.